Tirzepatide or alternative medications can be restarted if lifestyle measures prove insufficient, and there is no penalty for resuming treatment when medically appropriate
Sonne, D
Many pharmacies accept full sharps containers
approved as Marizev in Japan in 2015, [12] having been developed by Merck & Co
doi: 10.3389/fphar.2025.1710088 Received 21 September 2025 Revised 17 November 2025 Accepted 25 November 2025 Published 05 January 2026 Volume 16 - 2025 Edited by Sidharth Prasad Mishra, University of South Florida, United States Reviewed by Abdullah Shaito, Qatar University, Qatar Cosmin Mihai Vesa, University of Oradea, Romania Raquel de Cssia dos Santos, Sao Francisco University, Brazil Shengqian Sun, Yantai Institute of Technology, China Updates Copyright 2026 Rudrapal, de Oliveira and Singh
GLP-1 side effects: Whats normal, whats not, and when to get help